GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (NYSE:CRL) » Definitions » Price-to-Owner-Earnings

Charles River Laboratories International (Charles River Laboratories International) Price-to-Owner-Earnings : 25.89 (As of Apr. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Charles River Laboratories International Price-to-Owner-Earnings?

As of today (2024-04-26), Charles River Laboratories International's share price is $227.81. Charles River Laboratories International's Owner Earnings per Share (TTM) ended in Dec. 2023 was $8.80. It's Price-to-Owner-Earnings for today is 25.89.


The historical rank and industry rank for Charles River Laboratories International's Price-to-Owner-Earnings or its related term are showing as below:

CRL' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.97   Med: 21.93   Max: 43.68
Current: 25.89

During the past 13 years, the highest Price-to-Owner-Earnings of Charles River Laboratories International was 43.68. The lowest was 13.97. And the median was 21.93.


CRL's Price-to-Owner-Earnings is ranked worse than
54.41% of 68 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.315 vs CRL: 25.89

As of today (2024-04-26), Charles River Laboratories International's share price is $227.81. Charles River Laboratories International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $9.23. Therefore, Charles River Laboratories International's PE Ratio for today is 24.68.

As of today (2024-04-26), Charles River Laboratories International's share price is $227.81. Charles River Laboratories International's EPS without NRI for the trailing twelve months (TTM) ended in was $11.06. Therefore, Charles River Laboratories International's PE Ratio without NRI for today is 20.60.

During the past 13 years, Charles River Laboratories International's highest PE Ratio without NRI was 62.44. The lowest was 16.54. And the median was 24.68.


Charles River Laboratories International Price-to-Owner-Earnings Historical Data

The historical data trend for Charles River Laboratories International's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Price-to-Owner-Earnings Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.21 26.47 34.71 24.69 26.87

Charles River Laboratories International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.69 23.39 25.19 20.90 26.87

Competitive Comparison of Charles River Laboratories International's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Charles River Laboratories International's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Price-to-Owner-Earnings falls into.



Charles River Laboratories International Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Charles River Laboratories International's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=227.81/8.80
=25.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Charles River Laboratories International  (NYSE:CRL) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Charles River Laboratories International Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International (Charles River Laboratories International) Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Executives
Victoria L Creamer officer: EVP & Chief People Officer 164 PINE HILL ROAD, NEW FAIRFIELD CT 06812
Joseph W Laplume officer: EVP, Corp Strategy & Develop 251 BALLARDVALE STREET, WILMINGTON MA 01887
Birgit Girshick officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
James C Foster director, officer: President and CEO 251 BALLARDVALE ST, WILMINGTON MA 01887
Richard F Wallman director HONEYWELL, 101 COLUMBIA ROAD, MORRISTOWN NJ 07962
William D Barbo officer: Corporate Executive VP & CCO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Michael Gunnar Knell officer: CSVP&Chief Accounting Officer BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
George Massaro director
Shannon M Parisotto officer: CEVP, Disc & Safety Assessment 251 BALLARDVALE ST, WILMINGTON MA 01887
Flavia Pease officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
David Ross Smith officer: Corporate Executive VP & CFO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Deborah Turner Kochevar director 251 BALLARDVALE STREET, WILMINGTON MA 01887
Milne George M Jr director
Stephen D Chubb director C/O MATRITECH INC, 330 NEVADA STREET, NEWTON MA 02460
George Llado director 251 BALLARDVALE STREET, WILMINGTON MA 01887